Flossbach Von Storch Ag Bio N Tech Se Transaction History
Flossbach Von Storch Ag
- $22.7 Billion
- Q1 2025
A detailed history of Flossbach Von Storch Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Flossbach Von Storch Ag holds 4,259,631 shares of BNTX stock, worth $445 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
4,259,631
Previous 4,406,843
3.34%
Holding current value
$445 Million
Previous $502 Million
22.76%
% of portfolio
1.71%
Previous 2.03%
Shares
13 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$852 Million0.67% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$422 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$198 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$189 Million0.84% of portfolio
-
Capital International Investors Los Angeles, CA1.43MShares$149 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.3B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...